Imbalance of von Willebrand factor and ADAMTS13 axis is rather a biomarker of strong inflammation and endothelial damage than a cause of thrombotic process in critically ill COVID‐19 patients
出版年份 2021 全文链接
标题
Imbalance of von Willebrand factor and ADAMTS13 axis is rather a biomarker of strong inflammation and endothelial damage than a cause of thrombotic process in critically ill COVID‐19 patients
作者
关键词
-
出版物
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Volume 19, Issue 9, Pages 2193-2198
出版商
Wiley
发表日期
2021-07-05
DOI
10.1111/jth.15445
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- COVID-19 associated thrombotic thrombocytopenic purpura (TTP) ; A case series and mini-review
- (2021) Hamed Azhdari Tehrani et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Thrombotic thrombocytopenic Purpura as the initial Presentation of COVID‐19
- (2021) Marie‐Claude Beaulieu et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- von Willebrand Factor Multimer Formation Contributes to Immunothrombosis in Coronavirus Disease 2019
- (2021) Adrian A. N. Doevelaar et al. CRITICAL CARE MEDICINE
- ADAMTS 13 deficiency is associated with abnormal distribution of von Willebrand factor multimers in patients with COVID-19
- (2021) Tiffany Pascreau et al. THROMBOSIS RESEARCH
- No Evidence for Classic Thrombotic Microangiopathy in COVID-19
- (2021) Tanja Falter et al. Journal of Clinical Medicine
- Recombinant ADAMTS13 reduces abnormally up-regulated von Willebrand factor in plasma from patients with severe COVID-19
- (2021) Peter L. Turecek et al. THROMBOSIS RESEARCH
- Autoimmune thrombotic thrombocytopenic purpura (TTP) associated with COVID-19
- (2020) Nil Albiol et al. ANNALS OF HEMATOLOGY
- Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19
- (2020) Bérangère S. Joly et al. INTENSIVE CARE MEDICINE
- High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study
- (2020) Julie Helms et al. INTENSIVE CARE MEDICINE
- Clinical phenotypes of critically ill COVID-19 patients
- (2020) Elie Azoulay et al. INTENSIVE CARE MEDICINE
- D‐dimer levels on admission to predict in‐hospital mortality in patients with Covid‐19
- (2020) Litao Zhang et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- ADAMTS13 activity, von Willebrand factor, factor VIII and D-dimers in COVID-19 inpatients
- (2020) R. Escher et al. THROMBOSIS RESEARCH
- Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans
- (2020) Sharon E Fox et al. Lancet Respiratory Medicine
- Dramatic presentation of acquired TTP associated with COVID-19
- (2020) Marco Capecchi et al. HAEMATOLOGICA
- Current and Future Perspectives on ADAMTS13 and Thrombotic Thrombocytopenic Purpura
- (2020) Elien Roose et al. Hamostaseologie
- Role of von Willebrand Factor and ADAMTS-13 in the Pathogenesis of Thrombi in SARS-CoV-2 Infection: Time to Rethink
- (2020) Nuccia Morici et al. THROMBOSIS AND HAEMOSTASIS
- Microvascular dysfunction in COVID-19: the MYSTIC study
- (2020) Alexandros Rovas et al. ANGIOGENESIS
- A relative ADAMTS13 deficiency supports the presence of a secondary microangiopathy in COVID 19
- (2020) Nicola Martinelli et al. THROMBOSIS RESEARCH
- von Willebrand factor/ADAMTS13 axis and venous thromboembolism in moderate‐to‐severe COVID‐19 patients
- (2020) Maxime Delrue et al. BRITISH JOURNAL OF HAEMATOLOGY
- The ADAMTS13‐von Willebrand factor axis in COVID‐19 patients
- (2020) Ilaria Mancini et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- An open conformation of ADAMTS-13 is a hallmark of acute acquired thrombotic thrombocytopenic purpura
- (2018) E. Roose et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started